ClinicalTrials.gg
RecruitingNCT05107947LIFEUpdated Jan 12, 2026

Light in Frail Elderly - the Effect of a Dynamic Light for Sleep and Circadian Rhythm

An interventional study of Biocentric light in Aged, Circadian Rhythm and Cognition, sponsored by Region Skane. Recruiting at 1 site in Sweden. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-01-12.

Sponsored by Region Skane · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Oct 2022; still recruiting 4 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 43 studies in Fatigue with a site in Sweden — 14 open to participants now, 15 under way, none of them phase 3. Fatigue · Sweden.

Planned enrollment
3rd of 28
300 · median 70
Started
2022
with 2 others
No phase
26 of 43
9 open now
Primary completion
2028-03
later than 12 of 14 live
Registered
20th of 43
by date
Lead sponsor
3 of 43
Region Skane

Among the 43 studies in Fatigue with a site in Sweden, this one is the 3rd largest by planned enrollment of the 28 interventional ones that give a count, is one of 3 that started in 2022, is one of 26 with no phase, reaches primary completion later than 12 of the 14 other live ones, and was the 20th registered.

Fatigue

2,234 studies on the registry are indexed under Fatigue; 430 are open to participants now.

Browse Fatigue studies →

Open to participants now

14 of the 43 studies in Fatigue with a site in Sweden are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 242 Fatigue studies recruiting now, 113 (47%) set no upper age limit and 99 (41%) stop at 75 or younger; 23 take children under 18; 74 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 43 studies in Fatigue with a site in Sweden, or all of them as a file.
02

Study summary

The aim of this project is to evaluate the effect of a dynamic light in order to improve the circadian rhythm, provide a better sleep and well-being, and in the long run an improved recovery. The primary question is whether dynamic artificial light with circadian stimulus can affect the circadian rhythm. The secondary question is whether this also provides better sleep and well-being.

The group that is particularly interesting to study is a geriatric population that is more sensitive to circadian rhythm disorders, sleep disorders and confusion in connection with hospitalization and that can be of particular benefit from this intervention.

Read the detailed description

This is a randomized, prospective study where the diurnal variation of melatonin as well as sleep-related parameters (sleep duration and sleep quality) will be investigated with regards to light exposure during the hospital stay. Furthermore, it is investigated how psychological and cognitive functions are affected by light intervention and whether this is related to improved sleep or not. The study includes a total of 300 patients over the age of 65 who are cared for in an internal medicine or orthopedic surgery department at Skåne University Hospital in Malmö. The measurement period in the project is intended to be carried out during the period of October 2021-February 2022. Hospital rooms in the orthopedic department and in the medical department constitute the study environment. In all rooms, a biocentric lighting environment will be able to be created by activating a special lighting system. In these rooms, light will change dynamically both in spectral distribution and intensity during the day. During the day, color temperature and intensity are high (1000 lux and up to 6500 K) to decrease both intensity and color temperature during the evening. By weighing together spectral distribution and brightness, the circadian stimulus of the light environment can be calculated. The biocentric light provides a light with a high circadian stimulus during the morning and early afternoon. The biocentric light can be turned on (intervention) or off (control). When control setting, the standard normal light constitutes the light environment.

In all rooms included in the study, an accurate measurement of light conditions is carried out both with regard to spectral distribution and light intensity. Furthermore, patients will carry light meters to measure the actual amount of light to which patients are exposed. The study includes two arms, an intervention group and a control group. Patients who are assigned to one of the study rooms, and meet the inclusion criteria, will be asked to participate in the study. Patients are randomized to activate the biocentric light environment or standard light environment. The patients who are cared for in a biocentric light environment are included in the intervention group and those who are cared for in rooms with a standard light environment are included in the control group.

300 patients are to be included in the study. Surveys concerning alertness, sleep will be carried out. The frailty and a rapid test for delirium will be assessed. The patients will wear an actiwatch that records their sleep. For a small group of patients, also saliva melatonin will be collected every 4th hour from 7 pm to 11 am for two different nights 3 days apart. The results will be compared between the patients in the intervention group and the control group.

03

Conditions studied

  • Aged
  • Circadian Rhythm
  • Cognition
  • Fatigue
  • Humans
  • Light
  • Melatonin
  • Sleep
  • Biocentric
  • Frailty
  • Karolinska Sleepiness Score
  • Inflammation
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Over the age of 65 years
  • Admitted to one of the included study rooms

Exclusion criteria

Exclusion Criteria:

  • Overdose addictive substance
  • Acute neurological disease
  • Melatonin treatment
  • Probable survival \<5 days
  • Severe visual impairment that makes reading impossible
  • Age \<65 years
  • Inability to understand Swedish in speech and writing
  • Inability to consent to participate in the study
  • The patient is on any of the following medicines:

    • Medications for Parkinson's disease
    • Neuroleptics (including lithium)
    • Dementia
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    Intervention biocentric light environment

    In all study rooms, a biocentric lighting environment will be able to be created by activating a special lighting system. In these rooms, light will change dynamically both in spectral distribution and intensity during the day. During the day, color temperature and intensity are high (1000 lux and up to 6500 K) to decrease both intensity and color temperature during the evening.

    Other: Biocentric light

  • No intervention
    Control standard light environment

    Standard static light environment.

Interventions

  • OtherBiocentric light

    Light that changes in intensity and spectral distribution during the day to mimick daylight. High in intensity and high circadian stimulus during daytime and low intensity and low circadian stimulus during late afternoon and night.

06

What researchers measure

Primary outcomes

  1. Melatonin curve

    A change in the phase of the melatonin curve

    Time frame: Change after three days of biocentric light exposure

Secondary outcomes

  1. Sleep

    Change in sleep time

    Time frame: Increased total sleep time after three days of biocentric light exposure

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2022 (actual). Primary completion is estimated for Mar 2028, 65 months after the start.

Of 937 non-industry interventional studies with no phase under Fatigue, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 65 months is above that.

Counting every sponsor, half of 990 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 26, 2021
First posted
Nov 4, 2021
StartActual
Oct 31, 2022
Primary completionEst.
Mar 2028
CompletionEst.
Sep 2028
Last update
Jan 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05107947
Lead sponsor
Region Skane
Responsible party
Sponsor
First posted
Nov 4, 2021
Start date
Oct 31, 2022
Primary completion
Mar 2028 (estimated)
Completion
Sep 2028 (estimated)
Last update
Jan 12, 2026

Study contacts

Madeleine Selvander, MD, PhD
Contact
madeleine.selvander@med.lu.se
+4640 33 32 27
Klas Sjöberg, MD,PhD
Contact
klas.sjoberg@med.lu.se
+4640 33 32 27
Madeleine Selvander, MD, PhD
principal investigator · Lunds Universitet

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion